Zhongliang Zu

Dr. Zhongliang Zu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2022 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
JZJinyuan Zhou
Jinyuan Zhou
MZMoritz Zaiss
Moritz Zaiss
LKLinda Knutsson
Linda Knutsson
PSPhillip Sun
Phillip Sun
SASung Soo Ahn
Sung Soo Ahn
PZPeter C. M. van Zijl
Peter C. M. van Zijl
Amide proton transfer‐weighted (APTw) MR imaging shows promise as a biomarker of brain tumor status. Currently used APTw MRI pulse sequences and protocols vary substantially among different institutes, and there are no agreed‐on standards in the imaging community. Therefore, the results acquired from different research centers are difficult to compare, which hampers uniform clinical application and interpretation. This paper reviews current clinical APTw imaging approaches and provides a rationale for optimized APTw brain tumor imaging at 3 T, including specific recommendations for pulse sequences, acquisition protocols, and data processing methods. We expect that these consensus recommendations will become the first broadly accepted guidelines for APTw imaging of brain tumors on 3 T MRI systems from different vendors. This will allow more medical centers to use the same or comparable APTw MRI techniques for the detection, characterization, and monitoring of brain tumors, enabling multi‐center trials in larger patient cohorts and, ultimately, routine clinical use.

8 March 2017 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
XZXiao-Yong Zhang
Xiao-Yong Zhang
FWFeng Wang
Feng Wang
HLHua Li
Hua Li
JXJunzhong Xu
Junzhong Xu
DGDaniel F. Gochberg
Daniel F. Gochberg
ZZZhongliang Zu
Zhongliang Zu

1 October 2016 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
XZXiao-Yong Zhang
Xiao-Yong Zhang
FWFeng Wang
Feng Wang
AAAqeela Afzal
Aqeela Afzal
JXJunzhong Xu
Junzhong Xu
JGJohn C. Gore
John C. Gore
ZZZhongliang Zu
Zhongliang Zu

26 June 2017 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
XZXiao-Yong Zhang
Xiao-Yong Zhang
JXJingping Xie
Jingping Xie
FWFeng Wang
Feng Wang
ELEugene C. Lin
Eugene C. Lin
JXJunzhong Xu
Junzhong Xu
ZZZhongliang Zu
Zhongliang Zu


8 September 2016 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
XZXiao-Yong Zhang
Xiao-Yong Zhang
FWFeng Wang
Feng Wang
TJTao Jin
Tao Jin
JXJunzhong Xu
Junzhong Xu
JXJingping Xie
Jingping Xie
ZZZhongliang Zu
Zhongliang Zu
Purpose To detect, map, and quantify a novel nuclear Overhauser enhancement (NOE)‐mediated magnetization transfer (MT) with water at approximately −1.6 ppm [NOE(−1.6)] in rat brain using MRI. Methods Continuous wave MT sequences with a variety of radiofrequency irradiation powers were optimized to achieve the maximum contrast of this NOE(−1.6) effect at 9.4 T. The distribution of effect magnitudes, resonance frequency offsets, and line widths in healthy rat brains and the differences of the effect between tumors and contralateral normal brains were imaged and quantified using a multi‐Lorentzian fitting method. MR measurements on reconstituted model phospholipids as well as two cell lines (HEK293 and 9L) were also performed to investigate the possible molecular origin of this NOE. Results Our results suggest that the NOE(−1.6) effect can be detected reliably in rat brain. Pixel‐wise fittings demonstrated the regional variations of the effect. Measurements in a rodent tumor model showed that the amplitude of NOE(−1.6) in brain tumor was significantly diminished compared with that in normal brain tissue. Measurements of reconstituted phospholipids suggest that this effect may originate from choline phospholipids. Conclusion NOE(−1.6) could be used as a new biomarker for the detection of brain tumor. Magn Reson Med 78:588–597, 2017. © 2016 International Society for Magnetic Resonance in Medicine